Bernard Lambert

Title: Bernard Lambert: Innovator in Ovarian Carcinoma Research

Introduction

Bernard Lambert is a notable inventor based in Cabourg, France. He has made significant contributions to the field of medical research, particularly in the area of ovarian carcinoma. His work focuses on the predictive and prognostic use of microRNA in therapeutic care.

Latest Patents

Bernard Lambert holds a patent titled "Predictive and prognostic use of a miRNA for high grade serous ovarian carcinoma therapeutic care." This patent relates to the identification of a biomarker, consisting of a circulating miRNA, which is suitable for use in the diagnosis and prognosis of high-grade serous ovarian carcinoma (HGSOC). The patent also includes diagnostic kits designed for such diagnoses.

Career Highlights

Throughout his career, Bernard Lambert has worked with esteemed institutions such as Université de Caen Normandie and the Institut National de la Santé et de la Recherche Médicale. His research has contributed to advancements in understanding and treating ovarian cancer.

Collaborations

Some of his notable coworkers include Nicolas Vigneron and Christophe Denoyelle. Their collaborative efforts have furthered research in the field of oncology.

Conclusion

Bernard Lambert's innovative work in the realm of ovarian carcinoma research highlights the importance of microRNA as a diagnostic tool. His contributions continue to pave the way for advancements in therapeutic care for patients.